Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China (Q35632910)

9 August 2017

Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China (English)

1 reference

cost-effectiveness analysis

9 August 2017

1 reference

1 reference

People's Republic of China

inferred from title

0 references

1 reference

3

Margaret L Brandeau

1 reference

9 August 2017

David W Hutton

1

1 reference

PubMed ID

19839061

9 August 2017

Samuel K So

series ordinal

2

1 reference

PubMed ID

19839061

9 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

9 August 2017

1 reference

9 August 2017

51

1 reference

9 August 2017

405-414

1 reference

9 August 2017

2

1 reference

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Progress in the control of hepatitis B infection in the Western Pacific Region.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Treatment with interferons (including pegylated interferons) in patients with hepatitis B.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Prevention and control of hepatitis B in China

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Chronic type B hepatitis and the "healthy" HBsAg carrier state

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

27 July 2018

1 reference

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis

21 January 2018

1 reference

Cost of chronic hepatitis B infection in China.

21 January 2018

1 reference

The Cost Effectiveness of Hepatitis Immunization for US College Students

21 January 2018

1 reference

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam

21 January 2018

1 reference

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

21 January 2018

1 reference

Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.

21 January 2018

1 reference

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

21 January 2018

1 reference

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

21 January 2018

1 reference

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone

21 January 2018

1 reference

The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.

21 January 2018

1 reference

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population

21 January 2018

1 reference

Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience

21 January 2018

1 reference

A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore.

21 January 2018

1 reference

Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Study on the afficacy of hepatitis B immunization among youngsters in Beijing

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3245734

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

25 September 2018

1 reference

Estimating future hepatitis C morbidity, mortality, and costs in the United States

21 January 2018

1 reference

12 December 2020

Cost-effectiveness of hepatitis B vaccination of prison inmates

1 reference

12 December 2020

[Epidemiological effect of hepatitis B immunization among newborn babies in Beijing]

1 reference

12 December 2020

[Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma]

1 reference

12 December 2020

The influence of age on the development of the hepatitis B carrier state

1 reference

12 December 2020

Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness?

1 reference

12 December 2020

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

1 reference

12 December 2020

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma

1 reference

12 December 2020

The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma

1 reference

12 December 2020

[Long-term efficacy of infant hepatitis B immunization program]

1 reference

12 December 2020

Identifiers

DOI

10.1002/HEP.23310

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

PubMed ID

19839061